Trials / Unknown
UnknownNCT04281745
Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX®
A Single-arm Trial, Open-label, Repeated, Long-term, Multi-center, Phase IV Clinical Trial to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of Glabellar Lines With CORETOX®
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the long-term safety and efficacy of CORETOX in the treatment of moderate to severe glabellar lines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CORETOX Inj | Clostridium botulinum type A (Hall group); a lyophilized white power for injection with a colorless transparent vial. colorless transparent solution when dissolved with saline. |
Timeline
- Start date
- 2019-10-17
- Primary completion
- 2020-06-17
- Completion
- 2022-03-16
- First posted
- 2020-02-24
- Last updated
- 2020-07-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04281745. Inclusion in this directory is not an endorsement.